We studied the influence of Withania somnifera (Ws) root extract (100 mg/kg body weight) on parkinsonism induced by 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine (MPTP; i.p, 20 mg/kg body weight for 4 days), via the analysis of behavioral features and the oxidant-antioxidant imbalance in the midbrain of mice. A significant alteration in behavior, increased levels of thiobarbituric acid reactive substance (TBARS), and increased activities of superoxide dismutase (SOD) and catalase (CAT) were noticed in this region of brain in MPTP-treated mice. Oral treatment with the root extract resulted in a significant improvement in the mice’s behavoiur and antioxidant status, along with a significant reduction in the level of lipid peroxidation. The results indicated that at least part of the chronic stress-induced pathology may be due to oxidative stress, which is mitigated by Ws. Further studies are needed to assess the precise mechanism to support the clinical use of the plant as an antiparkinsonic drug.
Contents
-
April 28, 2007
-
Open AccessStilbene derivatives inhibit the activity of the inner mitochondrial membrane chloride channelsApril 25, 2007
-
Open AccessProcaspase-9 is attached to the mitochondrial outer membrane in the early stages of apoptosisApril 28, 2007
-
Open AccessThe identification of QTLs associated with the in vitro response of rye (Secale cereale L.)June 20, 2007
-
June 20, 2007
-
June 24, 2007
-
Open AccessThe expression of endothelin type A and B receptors in the lateral wall of the mouse cochleaJuly 3, 2007
-
Open AccessBrain proteins interacting with the tetramerization region of non-erythroid alpha spectrinJuly 3, 2007
-
August 30, 2007